Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Topsentinol L Trisulfate, a new Marine Natural Product, that Targets Basal-like and Claudin-low Breast Cancers

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.17.047555Source: DataRank Database

Topsentinol L Trisulfate, a new Marine Natural Product, that Targets Basal-like and Claudin-low Breast Cancers is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: greenTopics (39)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Thomas E. Smith ORCID,Gajendra Shrestha ORCID,Stephen Piccolo ORCID,Mary Kay Harper,Ryan M. Van Wagoner

Live enrichment

PubMed:19910364 OpenAlex:https://openalex.org/W3017316288

National Institutes of Health

Grant: 2R01CA036622-19

Antineoplastic Agents from Marine Organisms

National Institutes of Health

Grant: 5R01EY006671-13

Proximal retinal responses and the ERG

National Institutes of Health

Grant: 3P30CA042014-23S1

Protocol Review and Monitoring System

National Institutes of Health

Grant: 5U54CA209978-06

Combating Subclonal Evolution of Resistant Cancer Phenotypes

National Institutes of Health

Grant: 3P30CA042014-30S2

Cancer Center Support Grant

National Institutes of Health

Grant: 4U01CA164720-05

Integrative signaling models to decipher complex cancer phenotypes

National Institutes of Health

Grant: 1R01GM085601-01

Epigenetic changes and phenotype-specific therapeutic strategies in breast cancer

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2020/04/18/2020.04.17.047555.full.pdf

GREENhttps://www.mdpi.com/1660-3397/19/1/41/pdf?version=1611222655

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2020/04/18/2020.04.17.047555.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.04.17.047555

repositoryhttps://doi.org/10.1101/2020.04.17.047555

Fields of Study

Cancer Cells and MetastasisMetabolism, Diabetes, and CancerBone Metabolism and DiseasesBiologyMedicine0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Breast cancerAMPKCancer researchCancerBasal (medicine)ClaudinInternal medicineBiologyMedicineOncologyCell biologyTight junctionKinaseProtein kinase AQH301-705.5CHK1Antineoplastic AgentsBreast NeoplasmsAMP-Activated Protein Kinasesp38 Mitogen-Activated Protein Kinasesdrug susceptibilityArticleGene Expression Regulation, NeoplasticSterolsCell Line, Tumortopsentinol L trisulfateCheckpoint Kinase 1ClaudinsHumansFemaleBiology (General)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Life below water